These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 419132)

  • 1. Selective inhibition of glucagon and insulin secretion by somatostatin analogs.
    Voyles NR; Bhathena SJ; Recant L; Meyers CA; Coy DH
    Proc Soc Exp Biol Med; 1979 Jan; 160(1):76-9. PubMed ID: 419132
    [No Abstract]   [Full Text] [Related]  

  • 2. Relative effects of somatostatin and two somatostatin analogues on the release of insulin, glucagon and growth hormone.
    Efendić S; Luft R; Sievertsson H
    FEBS Lett; 1975 Oct; 58(1):302-5. PubMed ID: 1225595
    [No Abstract]   [Full Text] [Related]  

  • 3. Differential sensitivity to somatostatin of pancreatic polypeptide, glucagon and insulin secretion from the isolated perfused canine pancreas.
    Hermansen K; Schwartz TW
    Metabolism; 1979 Dec; 28(12):1229-33. PubMed ID: 514083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of exogenous insulin, glucagon, and somatostatin on islet hormone secretion in the perfused chicken pancreas.
    Honey RN; Fallon MB; Weir GC
    Metabolism; 1980 Dec; 29(12):1242-6. PubMed ID: 6109226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the mechanism of somatostatin action on insulin release. V. Effect of somatostatin analogues on arginine induced release of insulin and glucagon from the perfused rat pancreas.
    Efendić S; Lins PE; Luft R; Sievertsson H; Westin-Sjödal G
    Acta Endocrinol (Copenh); 1977 Jul; 85(3):579-86. PubMed ID: 194446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatostatin analogs inhibit somatostatin release.
    Ipp E; Rivier J; Dobbs RE; Brown M; Vale W; Unger RH
    Endocrinology; 1979 May; 104(5):1270-3. PubMed ID: 436775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of K+ and arginine on insulin, glucagon, and somatostatin release from the in vitro perfused rat pancreas.
    Frankel BJ; Heldt AM; Grodsky GM
    Endocrinology; 1982 Feb; 110(2):428-31. PubMed ID: 6120069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of somatostatin on the potentiating action of glucagon, cyclic adenosine monophosphate and theophylline on glucose-induced insulin release.
    Osorio J; Melani F; Verrillo A; Di Giacomo A; Campillo JE; Armentano V
    Diabete Metab; 1979 Mar; 5(1):27-31. PubMed ID: 221281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatostatin: analogs with selected biological activities.
    Brown M; Rivier J; Vale W
    Science; 1977 Jun; 196(4297):1467-9. PubMed ID: 867045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of glucagon and insulin secretion from the perfused rat pancreas by a B-cell-selective somatostatin analog.
    Weir GC; Schwarz JA; Mathe CJ
    Metabolism; 1980 Jan; 29(1):68-70. PubMed ID: 6986012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Starvation-induced changes of somatostatin, glucagon, and insulin secretion from the isolated perfused rat pancreas.
    Seino S; Sakurai H; Seino Y; Tsuda K; Tanigawa K; Kuzuya H; Goto Y; Imura H
    Diabetes; 1980 Apr; 29(4):323-5. PubMed ID: 6987123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interrelationship among insulin, glucagon and somatostatin secretory responses to exendin-4 in the perfused rat pancreas.
    Silvestre RA; Rodríguez-Gallardo J; Egido EM; Marco J
    Eur J Pharmacol; 2003 May; 469(1-3):195-200. PubMed ID: 12782202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Regulation mechanism of insulin and glucagon secretion from the isolated, perfused canine pancreas by somatostatin].
    Kawai K
    Horumon To Rinsho; 1983 May; 31(5):407-13. PubMed ID: 6136354
    [No Abstract]   [Full Text] [Related]  

  • 14. Gastrin releasing peptide stimulates the secretion of insulin, but not that of glucagon or somatostatin, from the isolated perfused dog pancreas.
    Hermansen K; Ahrén B
    Acta Physiol Scand; 1990 Feb; 138(2):175-9. PubMed ID: 1969219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological activity of somatostatin and somatostatin analogs on inhibtion of arginine-induced insulin and glucagon release in the rat.
    Brown M; Rivier J; Vale W
    Endocrinology; 1976 Feb; 98(2):336-43. PubMed ID: 813991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of glucagon antiserum on somatostatin, glucagon and insulin release from the isolated perfused rat pancreas.
    Seino S; Sakurai H; Kuzuya H; Tsuda K; Tanigawa K; Takahashi K; Seino Y; Imura H
    Peptides; 1982; 3(2):175-82. PubMed ID: 6124953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of somatostatin inhibition of insulin and glucagon secretion.
    Bhathena SJ; Perrino PV; Voyles NR; Smith SS; Wilkins SD; Coy DH; Schally AV; Recant L
    Diabetes; 1976 Nov; 25(11):1031-40. PubMed ID: 992224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic somatostatin is a mediator of glucagon inhibition by hyperglycemia.
    Klaff LJ; Taborsky GJ
    Diabetes; 1987 May; 36(5):592-6. PubMed ID: 2883057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haloperidol, a dopaminergic antagonist: somatostatin-like inhibition of glucagon and insulin release from the isolated, perfused canine pancreas.
    Hermansen K
    Diabetologia; 1978 Oct; 15(4):343-7. PubMed ID: 710756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ventromedial hypothalamic lesions on the secretion of somatostatin, insulin, and glucagon by the perfused rat pancreas.
    Goto Y; Carpenter RG; Berelowitz M; Frohman LA
    Metabolism; 1980 Oct; 29(10):986-90. PubMed ID: 6106879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.